Olivia Deitcher on Shifting From Transactional Prescriptions to Clinical Remission — Zest Health | VIVE 2026

Key Takeaways

• Dermatology wait times exceed six months in many US metros
• Zest Health uses virtual care to deliver high‑touch, value‑based treatment
• Goal: achieve clinical remission and safely de‑prescribe chronic meds
• Model aligns incentives of patients, providers, and payers
• Scaling and reimbursement contracts remain primary growth hurdles

Pulse Analysis

The chronic skin‑care market has long been plagued by bottlenecks that delay treatment and inflate costs. National data from the American Academy of Dermatology shows average wait times of over six months for new appointments in major metropolitan areas. During these delays, patients with conditions such as psoriasis often rely on intermittent prescriptions, leading to escalating pharmaceutical spend and suboptimal disease control. This transactional approach rewards high patient throughput rather than measurable health outcomes, creating a systemic inefficiency that strains both insurers and patients.

Zest Health’s virtual clinic flips the script by embedding value‑based principles into specialty dermatology. Leveraging telemedicine platforms, the company provides continuous, data‑driven care that addresses not only medication needs but also lifestyle, environmental triggers, and adherence coaching. Its ultimate clinical target is remission—defined as clear skin without the need for ongoing systemic therapy. By systematically reducing reliance on costly biologics, Zest aims to lower total cost of care while delivering a superior patient experience. The de‑prescription strategy aligns the clinic’s revenue with payer goals, as savings from reduced drug utilization directly benefit insurers.

If Zest Health can scale its high‑touch model, it may catalyze a broader shift across specialty medicine. Payers are increasingly interested in outcomes‑based contracts, and a proven virtual pathway to remission could unlock new reimbursement structures. However, the model’s success hinges on securing widespread payer agreements and maintaining the intensity of remote monitoring as patient volumes grow. Should these hurdles be overcome, Zest Health could become a blueprint for digitally enabled, value‑centric specialty care, prompting traditional clinics to re‑evaluate their reliance on prescription‑centric revenue streams.